Archives

by in
Entry Author Date Location
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut 07/24/13 Boston
East Coast Life Sciences Roundup: IBM, ImmunoGen, Breakthrough Prize, & More 02/22/13 New York
Facebook, Google Moguls Give $33M in Prizes to Biomedical Stars 02/20/13 National
Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage 10/11/11 Boston
Agios, Nourished with $130M Celgene Deal, Expanding Staff and Labs to Starve Cancer 08/19/10 Boston
Agios Pharmaceuticals Forges Ahead With Lab to Starve Cancer Cells 11/24/08 Boston
Page 1 of 1